Advancing drug discovery through expert ADME-Tox science
Admescope is a preclinical contract research organization (CRO) specialising in tailored ADME-Tox (Absorption, Distribution, Metabolism, Excretion and Toxicity), DMPK and quantitative bioanalysis services. We partner with pharmaceutical and biotechnology companies worldwide, delivering high-quality scientific data and expert guidance to support informed decision-making throughout drug discovery and preclinical development.
Based in Oulu, Finland, and part of the Symeres Group, Admescope combines scientific expertise with a collaborative, customer-focused approach. Every study is designed around your program, providing reliable data, practical insight and rapid turnaround times to help accelerate development while reducing risk.
Who We Are
At Admescope, we believe successful drug discovery begins with a thorough understanding of how compounds behave in biological systems. Our multidisciplinary team works closely with clients to provide tailored ADME-Tox and DMPK solutions that answer critical scientific questions and support confident progression through development.
From early lead optimisation to IND-enabling studies, we deliver robust, reproducible data alongside practical scientific interpretation. By acting as an extension of your team, we build long-term partnerships based on collaboration, transparency and scientific excellence.
Whether you’re developing small molecules, peptides, oligonucleotides, antibodies or antibody-drug conjugates (ADCs), our scientists provide the expertise needed to overcome development challenges and move your program forward.
Specialized Scientific Expertise
Our scientists combine decades of experience across drug metabolism, pharmacokinetics, bioanalysis and toxicology, allowing us to support a wide range of discovery and development program.
Our expertise includes:
- In Vitro Metabolism
- In Vivo DMPK
- Drug Interaction Studies
- Quantitative Bioanalysis
- Permeability & Transporters
- Physicochemistry & Binding
- In Vitro Toxicology
- Biologics
Rather than offering one-size-fits-all testing, every study is designed around your scientific objectives, ensuring you receive the data needed to make informed project decisions.
Flexible ADME-Tox Services
Every drug discovery program presents unique scientific challenges. That’s why flexibility is central to how we work.
Whether you require a single specialist assay, integrated ADME-Tox support or a customised DMPK strategy, our scientists collaborate closely with your team to design studies that align with your objectives, timelines and development milestones.
By tailoring study designs to each program, we help reduce development risk while generating high-quality data that supports confident decision-making throughout preclinical development.
Part of Symeres
Since becoming a Symeres company, Admescope has combined its specialist ADME-Tox expertise with access to a broader network of drug discovery and development capabilities.
Together, we provide integrated scientific support spanning medicinal chemistry, drug discovery, ADME-Tox, CMC development and pharmaceutical manufacturing. This enables customers to work with connected scientific teams throughout the drug development journey while maintaining the flexibility of specialist expertise.
Whether you require standalone ADME studies or integrated project support, our teams work together to help accelerate your path towards the clinic.
Vision, Mission & Core Values
At Admescope, our vision, mission and core values shape the way we work every day. They reflect our commitment to scientific excellence, quality, collaboration and building trusted partnerships that help pharmaceutical and biotechnology companies accelerate drug discovery and preclinical development.
From delivering reliable, high-quality ADME-Tox and DMPK data to providing responsive scientific support, our values underpin every project we undertake and every relationship we build.
Quality You Can Trust
Quality is at the heart of everything we do at Admescope. Our robust Quality Management System (QMS) supports every stage of our ADME-Tox, DMPK and quantitative bioanalysis services, helping ensure reliable, reproducible data, regulatory compliance and scientific excellence across every project.
From rigorous study design and validated methodologies to continuous training, quality control and ongoing process improvement, we are committed to delivering results our customers can trust. By combining experienced scientists, advanced technologies and a culture of continuous improvement, we help pharmaceutical and biotechnology companies make confident decisions throughout drug discovery and preclinical development.
